Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.85 AUD | -2.33% | -3.38% | -24.51% |
03:02am | Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments | MT |
Apr. 23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.51% | 1.6B | |
+27.92% | 672B | |
+26.97% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+7.26% | 217B | |
+5.61% | 199B | |
-8.47% | 204B | |
-8.58% | 149B |
- Stock Market
- Equities
- NEU Stock
- News Neuren Pharmaceuticals Limited
- FDA Approves Phase 2 Clinical Trial for Neuren Pharmaceuticals' Prader-Willi Syndrome Drug